On-demand webinar

Roche’s End-to-End R Journey to Submission

In the rapidly evolving landscape of pharmaceutical development, Roche showcases the use of open-source R in the regulatory submission process. In this webinar, the Roche team will share a pioneering experience of end-to-end R submission for a new drug application to the FDA, EMA, and NMPA.
Watch this webinar

What you’ll learn

Topic: Roche’s pioneering end-to-end R submission for New Drug Application to FDA, EMA, and NMPA using open-source tools
 
Problem: In the rapidly evolving pharmaceutical development landscape, Roche faced the groundbreaking challenge of conducting a complete regulatory submission using open-source R tools instead of traditional proprietary software. The team needed to navigate uncharted territory by building an entire NDA submission pipeline in R while ensuring regulatory agencies would accept and validate R-generated outputs. This required overcoming early challenges with clinical data workflows, establishing a validated R environment that met stringent regulatory standards, and demonstrating that open-source tools could support high-stakes regulatory work where drug approval decisions worth billions of dollars hung in the balance.
 
Solution: Roche developed a comprehensive approach to achieve their landmark regulatory submission entirely through open-source R tools:
  1. Built a complete eSubmission package within a validated R environment, addressing early workflow challenges by using R to clean, analyze, and visualize clinical trial data while incorporating open-source packages from the pharmaverse ecosystem.
  2. Established robust communication and collaboration processes with regulatory agencies (FDA, EMA, and NMPA), ensuring R-generated outputs would be accepted and validated as part of the official submission process.
  3. Created a replicable regulatory submission pipeline that demonstrates how open-source tools can successfully support critical pharmaceutical regulatory work, providing a proven model for the industry’s transition from proprietary to open-source submission workflows.

Join us at posit::conf(2025)

Don’t miss the chance to connect with data leaders, dive into hands-on sessions, and get inspired by the latest in open-source and enterprise data science.